Delivery Order SPE2DB20D3303-SPE2DB25FA1VE
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $47,064.36 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. This firm fixed-price, non-competitive delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $63,498.76 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, which was not set-aside, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $7,979.46 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 20 mg kits. This firm fixed-price, non-competitive delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $19,093.44 delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in endocrinology treatment. This firm fixed-price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents performance from AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,300.77 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits under a firm fixed price arrangement. This award was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside delivery order. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for Sandostatin LAR Depot 30 mg kits with a ceiling value of $76.7K. This firm fixed price delivery order, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive award to supply pharmaceutical products supporting federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sandostatin LAR Depot 20 mg kits. The $7,979.46 award has an ultimate completion date of April 24, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and government...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1VEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,965.76 to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg kits. The contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Sandostatin LAR Depot order fulfills federal medical supply requirements through the established competitive contracting vehicle, consistent with the company's demonstrated capability in delivering specialty pharmaceuticals and medical commodities across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 7/28/25 |